The journey of Lybrate


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
According to Quadria Capital, 70% of Indians live in rural areas where only 37% have access to inpatient care. Will Lybrate, a teleconsultation platform, bridge the unequal gap in India's healthcare?

While working for Facebook in The USA, Saurabh Arora came back to India for a vacation. Here, he happened to visit a chemist and was shocked to see how many people were buying self-prescribed or chemist-prescribed medicines. He knew the danger of buying medicines without the doctor’s consultation. He understood how hazardous the consequences of unprescribed medicines could be. Yet the prevalence of not consulting a doctor was common and rampant in India. 

So he decided to quit his job back in the States and start a venture with former Snapdeal employee Rahul Narang. They started Lybrate in 2013, which connected doctors and patients through one’s mobile. They wanted to make the activity of getting medicines smoother and ease filled. The telecommunication platform saw instant success. In the first half of 2015, it had 80,000 doctors with various specialisations and 1 lakh patients visiting every day. 

It rewrote the rules of investment of that time. In 2015, only 2% of investors’ capital would reach healthcare startups. But Lybrate attracted funding pretty easily despite investors' previous hesitation. It became India’s first institutionally funded teleconsultation startup. In 2014, they earned $1.2 million. The next year, they raised $10.2 million in their series A round. This round saw participation from Nexus Venture Partners, Tiger Global Management and Ratan Tata, Chairman Emeritus of Tata Sons. Their last funding round was in 2017, where Nexus helped raise $3 million in funds. They raised a total of $14.4 million in 3 funding rounds.

In 2015, Lybrate worked as a digital partner for Indian Medical Association and in May 2016, they launched Lybrate Lab+. This was an online lab service that allowed patients to give their samples from their homes and get results delivered to them. By 2019, Lybrate’s turnover for the year was Rs 22.45 crores. 60% of its customers came from tier 1 cities and the rest from tier 2 and tier 3 together. According to Quadria Capital, 70% of Indians live in rural areas where only 37% have access to inpatient care. 

Will Lybrate be able to penetrate deeper into the market by strategising to capture the rural market? Especially when acceptance of teleconsultation has increased since the Covid induced pandemic?

Tags : #Lybrate #SaurabhArora #RahulNarang #teleconsultation #investment #healthcarestartup #startup #Facebook #Snapdeal #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026